ENDOLOGIX INC's ticker is and the CUSIP is 29266SAA4. A total of 10 filers reported holding ENDOLOGIX INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,487,000 | -2.0% | 1,541,000 | 0.0% | 0.66% | +0.5% |
| Q2 2018 | $1,518,000 | +1.3% | 1,541,000 | 0.0% | 0.66% | +17.5% |
| Q1 2018 | $1,498,000 | +1.5% | 1,541,000 | 0.0% | 0.56% | +24.2% |
| Q4 2017 | $1,476,000 | 0.0% | 1,541,000 | 0.0% | 0.45% | +0.9% |
| Q3 2017 | $1,476,000 | 0.0% | 1,541,000 | 0.0% | 0.45% | +7.2% |
| Q2 2017 | $1,476,000 | – | 1,541,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 51,117,000 | $46,140,000 | 1.90% |
| PFM Health Sciences, LP | 6,445,000 | $5,809,000 | 0.16% |
| Partner Investment Management, L.P. | 84,000 | $76,000 | 0.10% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 5,562,000 | $5,013,000 | 0.09% |
| OAKTREE CAPITAL MANAGEMENT LP | 6,000,000 | $5,423,000 | 0.08% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,095,000 | $1,004,000 | 0.04% |
| ACUTA CAPITAL PARTNERS, LLC | 96,000 | $86,000 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,500,000 | $1,352,000,000 | 0.03% |
| AMUNDI ASSET MANAGEMENT US, INC. | 7,305,000 | $6,557,000 | 0.02% |
| Citadel Advisors | 6,230,000 | $5,624,000 | 0.01% |